메뉴 건너뛰기




Volumn 8, Issue 11, 2008, Pages 1649-1660

Lacosamide for the treatment of diabetic neuropathic pain

Author keywords

Diabetes; Lacosamide; Neuropathic pain

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYTOCHROME P450; DIGOXIN; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; METFORMIN; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; SODIUM CHANNEL; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE; ZONISAMIDE;

EID: 55849131767     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.11.1649     Document Type: Review
Times cited : (17)

References (89)
  • 1
    • 34548104636 scopus 로고    scopus 로고
    • Diabetic peripheral neuropathic pain: Recognition and management
    • Cole BE. Diabetic peripheral neuropathic pain: recognition and management. Pain Med. 8(Suppl. 2), S27-S32 (2007).
    • (2007) Pain Med , vol.8 , Issue.SUPPL. 2
    • Cole, B.E.1
  • 2
    • 34548144817 scopus 로고    scopus 로고
    • Diabetic peripheral neuropathic pain. Consensus guidelines for treatment
    • Diabetic peripheral neuropathic pain. Consensus guidelines for treatment. J. Fam. Pract. (Suppl.) 3-19 (2006).
    • (2006) J. Fam. Pract , Issue.SUPPL. , pp. 3-19
  • 3
    • 20144389536 scopus 로고    scopus 로고
    • Diabetic neuropathies: A statement by the American Diabetes Association
    • Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28(4), 956-962 (2005).
    • (2005) Diabetes Care , vol.28 , Issue.4 , pp. 956-962
    • Boulton, A.J.1    Vinik, A.I.2    Arezzo, J.C.3
  • 4
    • 0033988613 scopus 로고    scopus 로고
    • Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life
    • Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res. Clin. Pract. 47(2), 123-128 (2000).
    • (2000) Diabetes Res. Clin. Pract , vol.47 , Issue.2 , pp. 123-128
    • Galer, B.S.1    Gianas, A.2    Jensen, M.P.3
  • 5
    • 55849131161 scopus 로고    scopus 로고
    • duloxetine hydrochloride) delayed-release capsules prescribing information. Eli Lilly and Company
    • Indianapolis, USA 2007
    • Cymbalta® (duloxetine hydrochloride) delayed-release capsules prescribing information. Eli Lilly and Company, Indianapolis, IN, USA (2007).
    • Cymbalta®1
  • 6
    • 55849131927 scopus 로고    scopus 로고
    • pregabalin) prescribing information. Pfizer Inc
    • New York, NY, USA 2007
    • Lyrica® (pregabalin) prescribing information. Pfizer Inc. New York, NY, USA (2007).
    • Lyrica®1
  • 7
    • 33750048137 scopus 로고    scopus 로고
    • EFNS guidelines on pharmacological treatment of neuropathic pain
    • Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur. J. Neurol. 13(11), 1153-1169 (2006).
    • (2006) Eur. J. Neurol , vol.13 , Issue.11 , pp. 1153-1169
    • Attal, N.1    Cruccu, G.2    Haanpaa, M.3
  • 8
    • 0345445898 scopus 로고    scopus 로고
    • Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations
    • Dworkin RH, Backonja M, Rowbotham MC et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60(11), 1524-1534 (2003).
    • (2003) Arch. Neurol , vol.60 , Issue.11 , pp. 1524-1534
    • Dworkin, R.H.1    Backonja, M.2    Rowbotham, M.C.3
  • 9
    • 34248591500 scopus 로고    scopus 로고
    • Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society
    • Moulin DE, Clark AJ, Gilron I et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res. Manag. 12(1), 13-21 (2007).
    • (2007) Pain Res. Manag , vol.12 , Issue.1 , pp. 13-21
    • Moulin, D.E.1    Clark, A.J.2    Gilron, I.3
  • 10
    • 35748943212 scopus 로고    scopus 로고
    • Pharmacologic management of neuropathic pain: Evidence-based recommendations
    • Provides evidence-based recommendations for the treatment of neuropathic pain, •
    • Dworkin RH, O'Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132(3), 237-251 (2007). • Provides evidence-based recommendations for the treatment of neuropathic pain.
    • (2007) Pain , vol.132 , Issue.3 , pp. 237-251
    • Dworkin, R.H.1    O'Connor, A.B.2    Backonja, M.3
  • 11
    • 33645689140 scopus 로고    scopus 로고
    • Consensus guidelines: Treatment planning and options. Diabetic peripheral neuropathic pain
    • Includes guidelines from the DPNP Consensus Treatment Guidelines Advisory Board for the treatment of diabetic peripheral neuropathic pain, •
    • Argoff CE, Backonja MM, Belgrade MJ et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin. Proc. 81(4 Suppl.), S12-S25 (2006). • Includes guidelines from the DPNP Consensus Treatment Guidelines Advisory Board for the treatment of diabetic peripheral neuropathic pain.
    • (2006) Mayo Clin. Proc , vol.81 , Issue.4 SUPPL.
    • Argoff, C.E.1    Backonja, M.M.2    Belgrade, M.J.3
  • 12
    • 0029898015 scopus 로고    scopus 로고
    • Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives
    • Choi D, Stables JP, Kohn H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives. J. Med. Chem. 39(9), 1907-1916 (1996).
    • (1996) J. Med. Chem , vol.39 , Issue.9 , pp. 1907-1916
    • Choi, D.1    Stables, J.P.2    Kohn, H.3
  • 13
    • 34247855780 scopus 로고    scopus 로고
    • Lacosamide: A review of preclinical properties
    • Reviews the two proposed mechanisms of action of lacosamide and the efficacy of lacosamide in preclinical neuropathic pain models, ••
    • Beyreuther BK, Freitag J, Heers C, Krebsfanger N, Scharfenecker U, Stohr T. Lacosamide: a review of preclinical properties. CNS Drug. Rev. 13(1), 21-42 (2007). •• Reviews the two proposed mechanisms of action of lacosamide and the efficacy of lacosamide in preclinical neuropathic pain models.
    • (2007) CNS Drug. Rev , vol.13 , Issue.1 , pp. 21-42
    • Beyreuther, B.K.1    Freitag, J.2    Heers, C.3    Krebsfanger, N.4    Scharfenecker, U.5    Stohr, T.6
  • 14
    • 37349071555 scopus 로고    scopus 로고
    • The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels
    • Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels, ••
    • Errington AC, Stohr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol. Pharmacol. 73(1), 157-169 (2008). •• Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels.
    • (2008) Mol. Pharmacol , vol.73 , Issue.1 , pp. 157-169
    • Errington, A.C.1    Stohr, T.2    Heers, C.3    Lees, G.4
  • 15
    • 45749155596 scopus 로고    scopus 로고
    • Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N- benzyl-3-methoxypropanamide], lidocaine, and carbamazepine
    • Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels, ••
    • Sheets PL, Heers C, Stoehr T, Cummins TR. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N- benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J. Pharmacol. Exp. Ther. 326(1), 89-99 (2008). •• Describes the selective effects of lacosamide on slow inactivation of voltage-gated sodium channels.
    • (2008) J. Pharmacol. Exp. Ther , vol.326 , Issue.1 , pp. 89-99
    • Sheets, P.L.1    Heers, C.2    Stoehr, T.3    Cummins, T.R.4
  • 16
    • 34248183553 scopus 로고    scopus 로고
    • Proteome changes associated with hippocampal MRI abnormalities in the lithium pilocarpine-induced model of convulsive status epilepticus
    • Greene ND, Bamidele A, Choy M et al. Proteome changes associated with hippocampal MRI abnormalities in the lithium pilocarpine-induced model of convulsive status epilepticus. Proteomics 7(8), 1336-1344 (2007).
    • (2007) Proteomics , vol.7 , Issue.8 , pp. 1336-1344
    • Greene, N.D.1    Bamidele, A.2    Choy, M.3
  • 17
    • 39749159026 scopus 로고    scopus 로고
    • Proteomic analysis of stargazer mutant mouse neuronal proteins involved in absence seizure
    • Ryu MJ, Lee C, Kim J, Shin HS, Yu MH. Proteomic analysis of stargazer mutant mouse neuronal proteins involved in absence seizure. J. Neurochem. 104(5), 1260-1270 (2008).
    • (2008) J. Neurochem , vol.104 , Issue.5 , pp. 1260-1270
    • Ryu, M.J.1    Lee, C.2    Kim, J.3    Shin, H.S.4    Yu, M.H.5
  • 18
    • 33845225373 scopus 로고    scopus 로고
    • Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia
    • Katano T, Mabuchi T, Okuda-Ashitaka E, Inagaki N, Kinumi T, Ito S. Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. Proteomics 6(22), 6085-6094 (2006).
    • (2006) Proteomics , vol.6 , Issue.22 , pp. 6085-6094
    • Katano, T.1    Mabuchi, T.2    Okuda-Ashitaka, E.3    Inagaki, N.4    Kinumi, T.5    Ito, S.6
  • 19
    • 11144259374 scopus 로고    scopus 로고
    • Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy
    • Czech T, Yang JW, Csaszar E, Kappler J, Baumgartner C, Lubec G. Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy. Neurochem. Res. 29(12), 2189-2196 (2004).
    • (2004) Neurochem. Res , vol.29 , Issue.12 , pp. 2189-2196
    • Czech, T.1    Yang, J.W.2    Csaszar, E.3    Kappler, J.4    Baumgartner, C.5    Lubec, G.6
  • 20
    • 0002731330 scopus 로고    scopus 로고
    • Propagated signaling: The action potential
    • 4th Edition, Kandel ER, Schwartz JH, Jessell TM Eds, McGraw-Hill, New York, NY, USA
    • Koester J, Siegelbaum SA. Propagated signaling: the action potential. In: Principles of Neural Science (4th Edition). Kandel ER, Schwartz JH, Jessell TM (Eds). McGraw-Hill, New York, NY, USA 150-170 (2000).
    • (2000) Principles of Neural Science , pp. 150-170
    • Koester, J.1    Siegelbaum, S.A.2
  • 21
    • 55849091123 scopus 로고    scopus 로고
    • Lacosamide modulates collapsin response mediator protein 2 (CRMP-2) (Abstract)
    • Freitag J, Beyreuther B, Heers C, Stohr T. Lacosamide modulates collapsin response mediator protein 2 (CRMP-2) (Abstract). Neurology 68(12 Suppl. 1), A125 (2007).
    • (2007) Neurology , vol.68 , Issue.12 SUPPL. 1
    • Freitag, J.1    Beyreuther, B.2    Heers, C.3    Stohr, T.4
  • 22
    • 32844470254 scopus 로고    scopus 로고
    • Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain
    • Stöhr T, Krause E, Selve N. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain. Eur. J. Pain. 10(3), 241-249 (2006).
    • (2006) Eur. J. Pain , vol.10 , Issue.3 , pp. 241-249
    • Stöhr, T.1    Krause, E.2    Selve, N.3
  • 23
    • 33646882590 scopus 로고    scopus 로고
    • Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy
    • Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur. J. Pharmacol. 539(1-2), 64-70 (2006).
    • (2006) Eur. J. Pharmacol , vol.539 , Issue.1-2 , pp. 64-70
    • Beyreuther, B.1    Callizot, N.2    Stohr, T.3
  • 24
    • 55849094455 scopus 로고    scopus 로고
    • Lacosamide displays potent antinociceptive effects in animal models for neuropathic pain and inflammatory pain
    • Presented at:, Sydney, Australia, 21-26 August
    • Stöhr TBB, Selve N. Lacosamide displays potent antinociceptive effects in animal models for neuropathic pain and inflammatory pain. Presented at: 11th World Congress on Pain. Sydney, Australia, 21-26 August 2005.
    • (2005) 11th World Congress on Pain
    • Stöhr, T.B.B.1    Selve, N.2
  • 25
    • 34249035783 scopus 로고    scopus 로고
    • Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain
    • Beyreuther BK, Callizot N, Brot MD, Feldman R, Bain SC, Stohr T. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur. J. Pharmacol. 565(1-3), 98-104 (2007).
    • (2007) Eur. J. Pharmacol , vol.565 , Issue.1-3 , pp. 98-104
    • Beyreuther, B.K.1    Callizot, N.2    Brot, M.D.3    Feldman, R.4    Bain, S.C.5    Stohr, T.6
  • 26
    • 33751170209 scopus 로고    scopus 로고
    • Hao JX, Stohr T, Selve N, Wiesenfeld-Hallin Z, Xu XJ. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Eur. J. Pharmacol. 553(1-3), 135-140 (2006).
    • Hao JX, Stohr T, Selve N, Wiesenfeld-Hallin Z, Xu XJ. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Eur. J. Pharmacol. 553(1-3), 135-140 (2006).
  • 27
    • 33847410500 scopus 로고    scopus 로고
    • Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain
    • Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthritis Res. Ther. 9(1), R14 (2007).
    • (2007) Arthritis Res. Ther , vol.9 , Issue.1
    • Beyreuther, B.1    Callizot, N.2    Stohr, T.3
  • 28
    • 34047177848 scopus 로고    scopus 로고
    • Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF
    • Beyreuther BK, Geis C, Stohr T, Sommer C. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology 52(5), 1312-1317 (2007).
    • (2007) Neuropharmacology , vol.52 , Issue.5 , pp. 1312-1317
    • Beyreuther, B.K.1    Geis, C.2    Stohr, T.3    Sommer, C.4
  • 29
    • 40849086321 scopus 로고    scopus 로고
    • Lacosamide: An investigational drug for adjunctive treatment of partial-onset seizures
    • Ben-Menachem E. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures. Drugs Today (Barc.) 44(1), 35-40 (2008).
    • (2008) Drugs Today (Barc.) , vol.44 , Issue.1 , pp. 35-40
    • Ben-Menachem, E.1
  • 30
    • 0036752811 scopus 로고    scopus 로고
    • Progress report on new antiepileptic drugs: A summary of the Sixth Eilat Conference (EILAT VI)
    • Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E. Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res. 51(1-2), 31-71 (2002).
    • (2002) Epilepsy Res , vol.51 , Issue.1-2 , pp. 31-71
    • Bialer, M.1    Johannessen, S.I.2    Kupferberg, H.J.3    Levy, R.H.4    Loiseau, P.5    Perucca, E.6
  • 31
    • 11144232600 scopus 로고    scopus 로고
    • Basic clinical pharmacologic investigations of the new antiepileptic drug SPM 927 (Abstract)
    • Horstmann R, Bonn R, Cawello W, Doty P, Rudd GD. Basic clinical pharmacologic investigations of the new antiepileptic drug SPM 927 (Abstract). Epilepsia 43(Suppl. 7), 188 (2002).
    • (2002) Epilepsia , vol.43 , Issue.SUPPL. 7 , pp. 188
    • Horstmann, R.1    Bonn, R.2    Cawello, W.3    Doty, P.4    Rudd, G.D.5
  • 32
    • 33846194013 scopus 로고    scopus 로고
    • Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res. 73(1), 1-52 (2007).
    • Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res. 73(1), 1-52 (2007).
  • 33
    • 4644301804 scopus 로고    scopus 로고
    • Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res. 61(1-3), 1-48 (2004).
    • Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res. 61(1-3), 1-48 (2004).
  • 37
    • 33846244930 scopus 로고    scopus 로고
    • Pharmacokinetics of the new antiepileptic drug SPM 927 in human subjects with different age and gender (Abstract)
    • Schiltmeyer B, Cawello W, Kropeit D, Hammes W, Hortsmann R. Pharmacokinetics of the new antiepileptic drug SPM 927 in human subjects with different age and gender (Abstract). Epilepsia 46(Suppl. 7), 313 (2004).
    • (2004) Epilepsia , vol.46 , Issue.SUPPL. 7 , pp. 313
    • Schiltmeyer, B.1    Cawello, W.2    Kropeit, D.3    Hammes, W.4    Hortsmann, R.5
  • 39
    • 11144223136 scopus 로고    scopus 로고
    • Absence of effect of adjunctive SPM 927 on concomitant AED plasma concentrations in subjects with partial seizures
    • Fountain NB, Horstmann R, Cawello W, Doty P, Rudd GD. Absence of effect of adjunctive SPM 927 on concomitant AED plasma concentrations in subjects with partial seizures. Epilepsia 44(Suppl. 9), 96 (2003).
    • (2003) Epilepsia , vol.44 , Issue.SUPPL. 9 , pp. 96
    • Fountain, N.B.1    Horstmann, R.2    Cawello, W.3    Doty, P.4    Rudd, G.D.5
  • 40
    • 11144238504 scopus 로고    scopus 로고
    • SPM 927 does not interact with valproic acid and carbamazepine (Abstract)
    • Horstmann R, Bonn R, Cawello W, Doty P, Rudd GD. SPM 927 does not interact with valproic acid and carbamazepine (Abstract). Epilepsia 44(Suppl. 9), 97 (2003).
    • (2003) Epilepsia , vol.44 , Issue.SUPPL. 9 , pp. 97
    • Horstmann, R.1    Bonn, R.2    Cawello, W.3    Doty, P.4    Rudd, G.D.5
  • 41
    • 33846258011 scopus 로고    scopus 로고
    • Evaluation of the effect of oral lacosamide on concomitant AED plasma concentrations in patients with partial seizures (Abstract)
    • Jatuzis D, Biton V, Ben-Menachem E, Abou-Khalil B, Doty P, Rudd GD. Evaluation of the effect of oral lacosamide on concomitant AED plasma concentrations in patients with partial seizures (Abstract). Epilepsia 46(Suppl. 8), 170 (2005).
    • (2005) Epilepsia , vol.46 , Issue.SUPPL. 8 , pp. 170
    • Jatuzis, D.1    Biton, V.2    Ben-Menachem, E.3    Abou-Khalil, B.4    Doty, P.5    Rudd, G.D.6
  • 43
    • 39749167069 scopus 로고    scopus 로고
    • Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures
    • Multicenter, double-blind, doubledummy, randomized trial of intravenous lacosamide as a replacement for oral lacosamide in patients with partial-onset seizures, •
    • Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 49(3), 418-424 (2008). • Multicenter, double-blind, doubledummy, randomized trial of intravenous lacosamide as a replacement for oral lacosamide in patients with partial-onset seizures.
    • (2008) Epilepsia , vol.49 , Issue.3 , pp. 418-424
    • Biton, V.1    Rosenfeld, W.E.2    Whitesides, J.3    Fountain, N.B.4    Vaiciene, N.5    Rudd, G.D.6
  • 44
    • 55849095223 scopus 로고    scopus 로고
    • Pharmacokinetics and safety of intravenous lacosamide administered as replacement for adjunctive oral lacosamide in patients with partial-onset seizures (Abstract)
    • Rosenfeld WE, Biton V, Mameniskiene R et al. Pharmacokinetics and safety of intravenous lacosamide administered as replacement for adjunctive oral lacosamide in patients with partial-onset seizures (Abstract). Epilepsia 46(Suppl. 8), 184 (2005).
    • (2005) Epilepsia , vol.46 , Issue.SUPPL. 8 , pp. 184
    • Rosenfeld, W.E.1    Biton, V.2    Mameniskiene, R.3
  • 45
    • 0242558798 scopus 로고    scopus 로고
    • Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study
    • McCleane G, Koch B, Rauschkolb C. Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study. Neurosci. Lett. 352(2), 117-120 (2003).
    • (2003) Neurosci. Lett , vol.352 , Issue.2 , pp. 117-120
    • McCleane, G.1    Koch, B.2    Rauschkolb, C.3
  • 46
    • 33846477913 scopus 로고    scopus 로고
    • A report of the continuing analgesia after 12 months treatment with SPM 927 in six subjects with neuropathic pain
    • McCleane GJ, Koch B, Rauschkolb C. A report of the continuing analgesia after 12 months treatment with SPM 927 in six subjects with neuropathic pain. J. Neuropathic Pain Symptom Palliation 1(1), 25-28 (2005).
    • (2005) J. Neuropathic Pain Symptom Palliation , vol.1 , Issue.1 , pp. 25-28
    • McCleane, G.J.1    Koch, B.2    Rauschkolb, C.3
  • 47
    • 33846535387 scopus 로고    scopus 로고
    • Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a Phase 2 double-blind placebo-controlled study. Clin. J. Pain 23(2), 150-158 (2007). • Phase II multicenter, randomized, double-blind, placebo-controlled trial of lacosamide in diabetic neuropathic pain.
    • Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a Phase 2 double-blind placebo-controlled study. Clin. J. Pain 23(2), 150-158 (2007). • Phase II multicenter, randomized, double-blind, placebo-controlled trial of lacosamide in diabetic neuropathic pain.
  • 48
    • 0034748159 scopus 로고    scopus 로고
    • Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
    • Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2), 149-158 (2001).
    • (2001) Pain , vol.94 , Issue.2 , pp. 149-158
    • Farrar, J.T.1    Young Jr, J.P.2    LaMoreaux, L.3    Werth, J.L.4    Poole, R.M.5
  • 49
    • 0037406025 scopus 로고    scopus 로고
    • Clinically important changes in acute pain outcome measures: A validation study
    • Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J. Pain Symptom Manage. 25(5), 406-411 (2003).
    • (2003) J. Pain Symptom Manage , vol.25 , Issue.5 , pp. 406-411
    • Farrar, J.T.1    Berlin, J.A.2    Strom, B.L.3
  • 50
    • 55849134569 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742) (Abstract)
    • S
    • Wymer J. A multicenter, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742) (Abstract). Ann. Neurol. 60(Suppl. 11), S68 (2006).
    • (2006) Ann. Neurol , vol.60 , Issue.SUPPL. 11 , pp. 68
    • Wymer, J.1
  • 51
    • 55849104432 scopus 로고    scopus 로고
    • Efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742)
    • Presented at:, Colorado Springs, CO, USA, 15-18 April
    • Wymer J. Efficacy and safety of lacosamide in painful distal diabetic neuropathy (SP742). Presented at: College of Psychiatric and Neurologic Pharmacists 10th Annual Meeting. Colorado Springs, CO, USA, 15-18 April 2007.
    • (2007) College of Psychiatric and Neurologic Pharmacists 10th Annual Meeting
    • Wymer, J.1
  • 52
    • 55849148154 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide in subjects with painful distal diabetic neuropathy (SP743)
    • Presented at:, Sydney, Australia, 21-26 August
    • Ziegler D, Bongardt S, Thierfelder S, Koch B. A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide in subjects with painful distal diabetic neuropathy (SP743). Presented at: 11th World Congress on Pain. Sydney, Australia, 21-26 August 2005.
    • (2005) 11th World Congress on Pain
    • Ziegler, D.1    Bongardt, S.2    Thierfelder, S.3    Koch, B.4
  • 53
    • 55849092622 scopus 로고    scopus 로고
    • Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in painful distal diabetic neuropathy: results of a multi-center, placebo-controlled US trial (SP768) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 250 (2007).
    • Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in painful distal diabetic neuropathy: results of a multi-center, placebo-controlled US trial (SP768) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 250 (2007).
  • 54
    • 55849146771 scopus 로고    scopus 로고
    • Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, randomized, double-blind, placebo-controlled, parallel group trial (SP768). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
    • Shaibani A, Kenney P, Simpson J, Bongardt S. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, randomized, double-blind, placebo-controlled, parallel group trial (SP768). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
  • 56
    • 55849103286 scopus 로고    scopus 로고
    • UCB. Data presented at AAN show that lacosamide significantly reduced pain and was generally well tolerated in patients with diabetic neuropathic pain (media release) April 16 2008.
    • UCB. Data presented at AAN show that lacosamide significantly reduced pain and was generally well tolerated in patients with diabetic neuropathic pain (media release) April 16 2008.
  • 57
    • 55849115752 scopus 로고    scopus 로고
    • Evaluation of lacosamide in diabetic neuropathic pain trials (Abstract)
    • Shaibani A, Bongardt S, Sommerville K. Evaluation of lacosamide in diabetic neuropathic pain trials (Abstract). J. Pain 9(4), 21 (2008).
    • (2008) J. Pain , vol.9 , Issue.4 , pp. 21
    • Shaibani, A.1    Bongardt, S.2    Sommerville, K.3
  • 58
    • 55849087722 scopus 로고    scopus 로고
    • Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials. Presented at: The American Academy of Neurology 60th Annual Meeting. Chicago, IL, USA, 12-19 April 2008.
    • Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials. Presented at: The American Academy of Neurology 60th Annual Meeting. Chicago, IL, USA, 12-19 April 2008.
  • 59
    • 55849132301 scopus 로고    scopus 로고
    • Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with diabetic neuropathic pain: a summary of adverse events in four double-blind randomized clinical trials. Presented at: American Diabetes Association 68th Annual Meeting. San Francisco, CA, USA, 6-10 June 2008.
    • Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Lacosamide in patients with diabetic neuropathic pain: a summary of adverse events in four double-blind randomized clinical trials. Presented at: American Diabetes Association 68th Annual Meeting. San Francisco, CA, USA, 6-10 June 2008.
  • 60
    • 55849111283 scopus 로고    scopus 로고
    • Safety summary of lacosamide for treatment of diabetic neuropathic pain (Abstract)
    • Wymer J, Ziegler D, Sommerville K, Bongardt S, Shaibani A. Safety summary of lacosamide for treatment of diabetic neuropathic pain (Abstract). Diabetes 57(Suppl. 1), A158 (2008).
    • (2008) Diabetes , vol.57 , Issue.SUPPL. 1
    • Wymer, J.1    Ziegler, D.2    Sommerville, K.3    Bongardt, S.4    Shaibani, A.5
  • 61
    • 55849118203 scopus 로고    scopus 로고
    • Wymer J, Ziegler D, Sommerville K, Bongardt S. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials (Abstract). Neurology 70(Suppl. 1), A163 (2008).
    • Wymer J, Ziegler D, Sommerville K, Bongardt S. Lacosamide in patients with painful diabetic neuropathy: a summary of adverse events in four double-blind randomized clinical trials (Abstract). Neurology 70(Suppl. 1), A163 (2008).
  • 63
    • 55849090763 scopus 로고    scopus 로고
    • Long-term efficacy of lacosamide in subjects with diabetic neuropathic pain: Results of a double-blind, randomized withdrawal trial (SP746-1) (Abstract)
    • Hidvégi T, Bretschneider M, Thierfelder S, Sommerville K, Bongardt S. Long-term efficacy of lacosamide in subjects with diabetic neuropathic pain: results of a double-blind, randomized withdrawal trial (SP746-1) (Abstract). J. Pain 9(4), 27 (2008).
    • (2008) J. Pain , vol.9 , Issue.4 , pp. 27
    • Hidvégi, T.1    Bretschneider, M.2    Thierfelder, S.3    Sommerville, K.4    Bongardt, S.5
  • 64
    • 55849115753 scopus 로고    scopus 로고
    • Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial
    • Epub ahead of print, •• Long-term, multicenter, open-label extension trial of lacosamide in diabetic neuropathic pain
    • Shaibani A, Biton V, Rauck R, Koch B, Simpson J. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur. J. Pain. (2008) (Epub ahead of print). •• Long-term, multicenter, open-label extension trial of lacosamide in diabetic neuropathic pain.
    • (2008) Eur. J. Pain
    • Shaibani, A.1    Biton, V.2    Rauck, R.3    Koch, B.4    Simpson, J.5
  • 65
    • 55849114174 scopus 로고    scopus 로고
    • Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (SP745). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
    • Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (SP745). Presented at: European Federation of Neurological Societies Annual Meeting. Brussels, Belgium, 25-28 August 2007.
  • 66
    • 55849111284 scopus 로고    scopus 로고
    • Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (DNP) (SP745) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 260 (2007).
    • Graf R, Frye W, Simpson J, Jay G. Lacosamide in long-term treatment of painful diabetic neuropathy (DNP) (SP745) (Abstract). Eur. J. Neurol. 14(Suppl. 1), 260 (2007).
  • 67
    • 55849089329 scopus 로고    scopus 로고
    • Hidvégi T, Bretschneider M, Bongardt S, Koch B. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, open-label, follow-on trial (SP746). Presented at: American Pain Society 25th Annual Scientific Meeting. San Antonio, TX, USA, 3-6 May 2006.
    • Hidvégi T, Bretschneider M, Bongardt S, Koch B. Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, open-label, follow-on trial (SP746). Presented at: American Pain Society 25th Annual Scientific Meeting. San Antonio, TX, USA, 3-6 May 2006.
  • 68
    • 55849142016 scopus 로고    scopus 로고
    • A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy (SP746) (Abstract)
    • S
    • Bretschneider M, Bongardt S, Koch B. A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy (SP746) (Abstract). J. Pain 7(4), S43 (2006).
    • (2006) J. Pain , vol.7 , Issue.4 , pp. 43
    • Bretschneider, M.1    Bongardt, S.2    Koch, B.3
  • 69
    • 55849126802 scopus 로고    scopus 로고
    • Simpson K, Tzschaschel B, Bongardt S, Koch B. Lacosamide in patients with painful diabetic neuropathy: one year interim results from a long-term, multicenter, open-label trial (SP830). Presented at: Pain in Europe Congress. Istanbul, Turkey, 13-16 September 2006.
    • Simpson K, Tzschaschel B, Bongardt S, Koch B. Lacosamide in patients with painful diabetic neuropathy: one year interim results from a long-term, multicenter, open-label trial (SP830). Presented at: Pain in Europe Congress. Istanbul, Turkey, 13-16 September 2006.
  • 71
    • 0032477332 scopus 로고    scopus 로고
    • Symptomatic treatment of painful neuropathy
    • Low PA, Dotson RM. Symptomatic treatment of painful neuropathy. JAMA 280(21), 1863-1864 (1998).
    • (1998) JAMA , vol.280 , Issue.21 , pp. 1863-1864
    • Low, P.A.1    Dotson, R.M.2
  • 72
    • 52449093262 scopus 로고    scopus 로고
    • The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies
    • Deiderich NJ, Goetz CG. The placebo treatments in neurosciences: new insights from clinical and neuroimaging studies. Neurology 71(9), 677-684 (2008).
    • (2008) Neurology , vol.71 , Issue.9 , pp. 677-684
    • Deiderich, N.J.1    Goetz, C.G.2
  • 73
    • 0034328085 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group
    • Apfel SC, Schwartz S, Adornato BT et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284(17), 2215-2221 (2000).
    • (2000) JAMA , vol.284 , Issue.17 , pp. 2215-2221
    • Apfel, S.C.1    Schwartz, S.2    Adornato, B.T.3
  • 74
    • 34447344551 scopus 로고    scopus 로고
    • Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures
    • Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48(7), 1308-1317 (2007).
    • (2007) Epilepsia , vol.48 , Issue.7 , pp. 1308-1317
    • Ben-Menachem, E.1    Biton, V.2    Jatuzis, D.3    Abou-Khalil, B.4    Doty, P.5    Rudd, G.D.6
  • 75
    • 51449124170 scopus 로고    scopus 로고
    • Lacosamide: Efficacy and safety as oral adjunctive treatment for partial-onset seizures (SP754) (abstract)
    • Chung S, Sperling M, Biton V, Krauss G, Beaman M, Hebert D. Lacosamide: efficacy and safety as oral adjunctive treatment for partial-onset seizures (SP754) (abstract). Epilepsia 48(Suppl. 6), 321 (2007).
    • (2007) Epilepsia , vol.48 , Issue.SUPPL. 6 , pp. 321
    • Chung, S.1    Sperling, M.2    Biton, V.3    Krauss, G.4    Beaman, M.5    Hebert, D.6
  • 76
    • 33846220582 scopus 로고    scopus 로고
    • Lacosamide: Efficacy and safety as oral adjunctive therapy in adults with partial seizures (SP755) (Abstract)
    • Halász P, Kälviäinen R, Mazurkiewicz-Beldzinska M, Rosenow F, Doty P, Sullivan T. Lacosamide: efficacy and safety as oral adjunctive therapy in adults with partial seizures (SP755) (Abstract). Epilepsia 47(Suppl. 4), 3 (2006).
    • (2006) Epilepsia , vol.47 , Issue.SUPPL. 4 , pp. 3
    • Halász, P.1    Kälviäinen, R.2    Mazurkiewicz-Beldzinska, M.3    Rosenow, F.4    Doty, P.5    Sullivan, T.6
  • 80
    • 55849084406 scopus 로고    scopus 로고
    • UCB. UCB receives not-approvable letter from FDA for lacosamide for diabetic neuropathic pain (media release) July 29 (2008) www.ucb-group.com/news/ 3572.asp
    • UCB. UCB receives not-approvable letter from FDA for lacosamide for diabetic neuropathic pain (media release) July 29 (2008) www.ucb-group.com/news/ 3572.asp
  • 81
    • 55849146407 scopus 로고    scopus 로고
    • UCB. UCB withdraws EU marketing authorization application for lacosamide in diabetic neuropathic pain (media release) September 25 (2008) www.ucb-group.com/news/3629.asp
    • UCB. UCB withdraws EU marketing authorization application for lacosamide in diabetic neuropathic pain (media release) September 25 (2008) www.ucb-group.com/news/3629.asp
  • 84
    • 55849091492 scopus 로고    scopus 로고
    • A multicenter, open-label trial to assess the safety and tolerability of a single intravenous loading dose of lacosamide followed by oral lacosamide maintenance as adjunctive therapy in subjects with partial-onset seizures NLM identifier: NCT00655551 www.clinicaltrials.gov/ct2/show/ NCT00655551
    • A multicenter, open-label trial to assess the safety and tolerability of a single intravenous loading dose of lacosamide followed by oral lacosamide maintenance as adjunctive therapy in subjects with partial-onset seizures NLM identifier: NCT00655551 www.clinicaltrials.gov/ct2/show/ NCT00655551


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.